REGULATION OF CYCLIC NUCLEOTIDE FORMATION AND ACTION

Information

  • Research Project
  • 3229643
  • ApplicationId
    3229643
  • Core Project Number
    R01DK030787
  • Full Project Number
    5R01DK030787-10
  • Serial Number
    30787
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1989 - 35 years ago
  • Project End Date
    5/31/1992 - 32 years ago
  • Program Officer Name
  • Budget Start Date
    6/1/1990 - 34 years ago
  • Budget End Date
    5/31/1991 - 33 years ago
  • Fiscal Year
    1990
  • Support Year
    10
  • Suffix
  • Award Notice Date
    9/19/1990 - 34 years ago
Organizations

REGULATION OF CYCLIC NUCLEOTIDE FORMATION AND ACTION

The specific aims of this proposal are to determine the mechanisms of hormone, autocoid and drug regulation of the isoenzyme forms of guanylate cyclase and cyclic GMP synthesis. The precise mechanisms involved in hormone receptor coupling to the different guanylate cyclase isoenzymes will be examined in considerable detail. Experiments will utilize intacts cell cultures and tissues as well as crude and purified components and their reconstitution in cell-free preparations. The effects of atrial natriuretic factor and E. coli heat-stable enterotoxin on cyclic GMP synthesis as well as other ligands and hormones will serve as models and prototypes for these studies. The effects of ATP and other nucleotides and a recently purified protein activator of guanylate cyclase will also be examined. The role of these materials as well as protein phosphorylation and dephosphorylation in guanylate cyclase regulation and hormone coupling to cyclic GMP synthesis will be examined. Methods will include the purification and characterization of coupling factors for hormonal regulation of guanylate cyclase and their functional reconstitution. These studies are expected to increase our understanding of the role of cyclic GMP as a fundamental second messenger to mediate hormone effects and, thus, should provide mechanisms to modify biochemical and physiological responses in normal and pathological states.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R01
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    PHRA
  • Study Section Name
    Pharmacology A Study Section
  • Organization Name
    ABBOTT LABORATORIES
  • Organization Department
  • Organization DUNS
  • Organization City
    NORTH CHICAGO
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    60064
  • Organization District
    UNITED STATES